![Alise Reicin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alise Reicin
Director/Board Member at
SANA BIOTECHNOLOGY, INC.
Net worth: 14 M $ as of 2026-05-30
Profile
Alise S.
Reicin is President, Chief Executive Officer & Director at Tectonic Therapeutic, Inc. and Tectonic Operating Co., Inc. since 2020.
Also holds roles as Non-Executive Director at Immatics NV since 2024, Director at Sharsheret, Inc., Independent Director at Sana Biotechnology, Inc. since 2020, and Venture Advisor at Israel Biotech Fund.
Formerly Chief Executive Officer & Director at AVROBIO, Inc., Independent Director at Homology Medicines, Inc., President-Global Clinical Development at Celgene Corp.
from 2018 to 2019, VP-Oncology Program & Pipeline Leadership at Merck & Co., Inc., and SVP & Head-Global Clinical Development at EMD Serono, Inc. from 2015 to 2018.
Education includes an undergraduate degree from Barnard College in 1982 and a doctorate from Harvard Medical School in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
2.32% | 2026-06-19 | 437,653 ( 2.32% ) | 14 M $ | 2026-05-30 |
IMMATICS N.V. -.--% | 2026-06-15 | 0 ( -.--% ) | - $ | 2026-05-30 |
| 2026-06-03 | 0 ( -.--% ) | - $ | 2026-05-30 |
Alise Reicin active positions
| Companies | Position | Start |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 2020-11-30 |
| IMMATICS N.V. | Director/Board Member | 2024-07-28 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Chief Executive Officer | 2020-07-31 |
Sharsheret, Inc.
 Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Non-Profit Organization | Director/Board Member | - |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Former positions of Alise Reicin
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2019-11-30 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Chief Tech/Sci/R&D Officer | 2018-09-30 |
| TECTONIC THERAPEUTIC, INC. | Chief Executive Officer | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Alise Reicin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sharsheret, Inc.
Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Non-Profit Organization | Commercial Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
- Stock Market
- Insiders
- Alise Reicin
